The Kaplan–Meier analyses showed that high ZFP90 expression was associated with a poor prognosis in CRC patients in Cohort 2 (Fig. S4f) and an independent CRC database (Fig. S4g). Here, ZFP90 is linked to colorectal carcinoma.